Loading…
Alpa Laboratories (ALPA)₹56.58+1.16%Pharmaceuticals
Alpa Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 28.6 against a peer median of 21.9, and ROCE of 9.1% against a peer median of 9.0%, and latest-quarter sales growth of 25.3% against a peer median of 27.4%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | vs ALPA |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | vs ALPA |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs ALPA |
| Asston Pharmaceuticals | 129 | 33.3 | 16.8 | 15.5 | 0.13 | 0.0 | 25 | 4 | 10.8 | −75.8 | vs ALPA |
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | vs ALPA |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs ALPA |
| Godavari Drugs | 122 | 24.2 | 7.0 | 6.4 | 1.00 | 0.0 | 106 | 4 | 30.1 | 45.5 | vs ALPA |
| Alpa Laboratories | 119 | 28.6 | 9.1 | 8.3 | 0.02 | 0.0 | 106 | 15 | 25.3 | −91.6 | — |
| Makers Laboratories | 111 | 14.9 | 9.0 | 3.2 | 0.05 | 0.0 | 141 | 8 | 41.0 | 1,064.4 | vs ALPA |
| Tyche Industries | 109 | 15.9 | 6.8 | 5.0 | 0.00 | 2.8 | 54 | 7 | 31.0 | 22.1 | vs ALPA |
| Pharmaids Pharmaceuticals | 106 | — | −18.4 | −26.5 | 0.49 | 0.0 | 28 | −12 | −38.2 | — | vs ALPA |
| Peer median | 125 | 21.9 | 9.0 | 7.1 | 0.36 | 0.0 | 106 | 6 | 27.4 | 45.5 |
Listed companies closest to Alpa Laboratories in Pharmaceuticals include Bal Pharma, Lactose (India), Krebs Biochemicals and Industries, Asston Pharmaceuticals, BALAXI PHARMACEUTICALS, Parnax Lab, Godavari Drugs, Makers Laboratories.
Bal Pharma, with a market cap of ₹132 Cr.
Alpa Laboratories trades at a P/E of 28.6; the median of its peer set is 21.9. A P/E above or below the median is a description, not a judgement on value.
Alpa Laboratories' return on capital employed is 9.1%, above the peer median of 9.0%.